Tonix Pharmaceuticals Holding Corp. (TNXP) Insider Trading -- Recent Executive & Director Transactions

10 insiders reported 17 Form 4 transactions for Tonix Pharmaceuticals Holding Corp. (TNXP) over the past 18 months (most recent 2026-06-09). Recent activity: LEDERMAN SETH (Chief Executive Officer) Buy 5,000 shares, Stillwell Richard Newcomb (Director) Buy 5,000 shares, LEDERMAN SETH (Chief Executive Officer) Buy 15,000 shares, SAENGER BRADLEY (Chief Financial Officer) Buy 701 shares, Taylor Carolyn E. (Director) Buy 418 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-09LEDERMAN SETHChief Executive OfficerBuy5,000$58,950
2026-06-09Stillwell Richard NewcombDirectorBuy5,000$58,250
2026-03-18LEDERMAN SETHChief Executive OfficerBuy15,000$223,350
2026-02-17SAENGER BRADLEYChief Financial OfficerBuy701$9,407
2025-08-21Taylor Carolyn E.DirectorBuy418$15,061
2025-08-20Treco JamesDirectorBuy250$9,000
2025-05-15LEDERMAN SETHChief Executive OfficerBuy4,000$86,200
2025-02-28OLUKOTUN ADEOYE YDirectorSell1$2
2025-02-28Bell Margaret SmithDirectorSell1$0
2025-02-28Treco JamesDirectorSell0$0
2025-02-28BAGGER RICHARD HDirectorSell0$0
2025-02-27SULLIVAN GREGORY MChief Medical OfficerSell0$0
2025-02-27MORRIS JESSICA EDGARChief Operating OfficerSell1$0
2025-02-27SAENGER BRADLEYChief Financial OfficerSell0$0
2025-02-27LEDERMAN SETHChief Executive OfficerSell5$18
2025-02-27LEDERMAN SETHChief Executive OfficerSell0$1
2025-02-27LEDERMAN SETHChief Executive OfficerSell1$0

Source: SEC Form 4 filings · as of 2026-06-09